OMCL
OMCL
NASDAQ · Health Care

Omnicell Inc

$39.41
+3.95 (+11.14%)
Financial Highlights (FY 2026)
Revenue
1.16B
Net Income
2.01M
Gross Margin
42.9%
Profit Margin
0.2%
Rev Growth
-2.9%
D/E Ratio
0.14
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 42.9% 42.9% 58.8% 58.8%
Operating Margin 0.4% 0.4% 6.3% 6.3%
Profit Margin 0.2% 0.2% 4.9% 5.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.16B 1.20B 1.69B 1.69B
Gross Profit 498.38M 513.48M 993.37M 997.17M
Operating Income 5.11M 4.74M 105.91M 107.52M
Net Income 2.01M 1.87M 82.52M 97.89M
Gross Margin 42.9% 42.9% 58.8% 58.8%
Operating Margin 0.4% 0.4% 6.3% 6.3%
Profit Margin 0.2% 0.2% 4.9% 5.8%
Rev Growth -2.9% -2.9% -3.3% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 100.46M 100.46M 510.00M 606.53M
Total Equity 738.17M 738.17M 603.03M 581.87M
D/E Ratio 0.14 0.14 0.85 1.04
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 82.36M 80.61M 161.95M 137.80M
Free Cash Flow — — 61.22M 53.55M